ZUP1 and AL amyloidosis: Despite these setbacks, the unique mechanism of action of DUB inhibitors in Bortezomib-resistant multiple myeloma has prompted further research, including the development of a rat model to assess VLX1570-induced lung toxicity and the development of specific DUB inhibitors [199].